PCAS SA (0NF7.L)

6.34 +6.34 (-29.64%) At close: 05:57PM BST

PCAS SA

21, chemin de la sauvegarde
Écully
Longjumeau 69134
France
33 1 69 09 77 85
https://www.pcas.com

Sector(s): 
Industry: 
Full-time employees: 1,180

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jean-Louis Martin	Acting CEO & Director	N/A	N/A	N/A
Mr. Eric Moissenot	Gen. Director of Fin. & Admin.	N/A	N/A	N/A
Mr. Gérard Guillamot	Scientific Director	N/A	N/A	N/A
Mr. Christophe Eychenne-Baron	Head of R&D	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

PCAS SA develops and produces complex molecules for life sciences and technologies. The company was founded in 1962 and is headquartered in Longjumeau, France. PCAS SA is a subsidiary of Seqens SAS

Corporate governance

PCAS SA’s ISS governance QualityScore as of 1 March 2023 is 10. The pillar scores are Audit: 8; Board: 10; Shareholder rights: 9; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.